New study reveals Dupilumab's impact on aspirin sensitivity in severe asthma
NCT ID NCT05031455
First seen Apr 28, 2026 · Last updated May 26, 2026 · Updated 3 times
Summary
This study looked at how dupilumab, a medication for asthma and nasal polyps, affects reactions to aspirin in people with Aspirin-Exacerbated Respiratory Disease (AERD). Sixteen adults already taking dupilumab for at least 12 weeks underwent an aspirin challenge to see if the drug changes their hypersensitivity response. The goal was to understand dupilumab's effect on the aspirin desensitization process, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPIRIN-EXACERBATED RESPIRATORY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Scripps Clini
San Diego, California, 92130, United States
Conditions
Explore the condition pages connected to this study.